Literature DB >> 30283273

Low-Frequency Blood Group Antigens in Switzerland.

Christoph Gassner1, Frauke Degenhardt2, Stefan Meyer1, Caren Vollmert3, Nadine Trost1, Kathrin Neuenschwander1, Yvonne Merki1, Claudia Portmann1, Sonja Sigurdardottir1, Antigoni Zorbas4, Charlotte Engström4, Jochen Gottschalk4, Soraya Amar El Dusouqui5, Sophie Waldvogel-Abramovski5, Emmanuel Rigal5, Jean-Daniel Tissot6, Caroline Tinguely7, Simon M Mauvais8, Amira Sarraj8, Daniel Bessero9, Michele Stalder9, Laura Infanti10, Andreas Buser10, Jörg Sigle11, Tina Weingand12, Damiano Castelli13, Monica C Braisch14, Jutta Thierbach14, Sonja Heer15, Thomas Schulzki15, Michael Krawczak16, Andre Franke2, Beat M Frey4.   

Abstract

BACKGROUND: High-frequency blood group antigens (HFA) are present in >90% of the human population, according to some reports even in >99% of individuals. Therefore, patients lacking HFA may become challenging for transfusion support because compatible blood is hardly found, and if the patient carries alloantibodies, the cross-match will be positive with virtual every red cell unit tested.
METHODS: In this study, we applied high-throughput blood group SNP genotyping on >37,000 Swiss blood donors, intending to identify homozygous carriers of low-frequency blood group antigens (LFA).
RESULTS: 326 such individuals were identified and made available to transfusion specialists for future support of patients in need of rare blood products.
CONCLUSION: Thorough comparison of minor allele frequencies using population genetics revealed heterogeneity of allele distributions among Swiss blood donors which may be explained by the topographical and cultural peculiarities of Switzerland. Moreover, geographically localized donor subpopulations are described which contain above-average numbers of individuals carrying rare blood group genotypes.

Entities:  

Keywords:  Blood group allele; Blood groups; High-frequency antigen; Low-frequency antigen; Population genetics; Rare donor panel/program; Rare/molecular blood group; Switzerland

Year:  2018        PMID: 30283273      PMCID: PMC6158591          DOI: 10.1159/000490714

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  23 in total

Review 1.  Considerations of red blood cell molecular testing in transfusion medicine.

Authors:  Annika M Svensson; Meghan Delaney
Journal:  Expert Rev Mol Diagn       Date:  2015-09-14       Impact factor: 5.225

2.  The genetical structure of populations.

Authors:  S WRIGHT
Journal:  Ann Eugen       Date:  1951-03

3.  Genetic diversity of KELnull and KELel: a nationwide Austrian survey.

Authors:  Günther F Körmöczi; Thomas Wagner; Christof Jungbauer; Maria Vadon; Norbert Ahrens; Willi Moll; Annelies Mühlbacher; Seyhan Ozgül-Gülce; Thomas Kleinrath; Susanne Kilga-Nogler; Diether Schönitzer; Christoph Gassner
Journal:  Transfusion       Date:  2007-04       Impact factor: 3.157

4.  MENDELIAN PROPORTIONS IN A MIXED POPULATION.

Authors:  G H Hardy
Journal:  Science       Date:  1908-07-10       Impact factor: 47.728

5.  Silent KEL alleles identified from Japanese individuals with the Ko phenotype.

Authors:  T Onodera; M Kawai; K Obara; T Enomoto; K Sasaki; T Osabe; K Ogasawara; C Toyoda; H Tsuneyama; M Uchikawa; S Inaba; M Satake
Journal:  Vox Sang       Date:  2017-12-27       Impact factor: 2.144

6.  Genetic differences between five European populations.

Authors:  Valentina Moskvina; Michael Smith; Dobril Ivanov; Douglas Blackwood; David StClair; Christina Hultman; Draga Toncheva; Michael Gill; Aiden Corvin; Colm O'Dushlaine; Derek W Morris; Naomi R Wray; Patrick Sullivan; Carlos Pato; Michele T Pato; Pamela Sklar; Shaun Purcell; Peter Holmans; Michael C O'Donovan; Michael J Owen; George Kirov
Journal:  Hum Hered       Date:  2010-07-08       Impact factor: 0.444

7.  Molecular Basis of KELnull Phenotype in Brazilians.

Authors:  Edmir Boturão-Neto; Mihoko Yamamoto; Akemi Kuroda Chiba; Elisa Yuriko Sugano Kimura; Maria do Carmo Valgueiro Costa de Oliveira; Cláudia Lumack do Monte Barretto; Mércia Maria Alves Nunes; Sérgio Roberto Lopes Albuquerque; Marcos Daniel de Deus Santos; José Orlando Bordin
Journal:  Transfus Med Hemother       Date:  2014-12-19       Impact factor: 3.747

Review 8.  International rare donor panels: a review.

Authors:  S Nance; E A Scharberg; N Thornton; V Yahalom; I Sareneva; C Lomas-Francis
Journal:  Vox Sang       Date:  2015-12-21       Impact factor: 2.144

9.  Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype.

Authors:  Jill R Storry; Magnus Jöud; Mikael Kronborg Christophersen; Britt Thuresson; Bo Åkerström; Birgitta Nilsson Sojka; Björn Nilsson; Martin L Olsson
Journal:  Nat Genet       Date:  2013-04-07       Impact factor: 38.330

10.  Scianna antigens including Rd are expressed by ERMAP.

Authors:  Franz F Wagner; Joyce Poole; Willy A Flegel
Journal:  Blood       Date:  2002-08-22       Impact factor: 22.113

View more
  4 in total

1.  Towards a Regional Registry of Extended Typed Blood Donors: Molecular Typing for Blood Group, Platelet and Granulocyte Antigens.

Authors:  Jan Portegys; Gabi Rink; Pia Bloos; Erwin A Scharberg; Harald Klüter; Peter Bugert
Journal:  Transfus Med Hemother       Date:  2018-09-24       Impact factor: 3.747

2.  Molecular Blood Group Screening in Donors from Arabian Countries and Iran Using High-Throughput MALDI-TOF Mass Spectrometry and PCR-SSP.

Authors:  Brigitte Katharina Flesch; Vanessa Scherer; Burkhard Just; Andreas Opitz; Oswin Ochmann; Anne Janson; Monika Steitz; Thomas Zeiler
Journal:  Transfus Med Hemother       Date:  2020-01-22       Impact factor: 3.747

3.  When recombinant proteins can replace rare red cells in immunohematology workups.

Authors:  Willy A Flegel; Kshitij Srivastava
Journal:  Transfusion       Date:  2021-05-31       Impact factor: 3.337

4.  Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation.

Authors:  Louisa Goumidi; Florian Thibord; Kerri L Wiggins; Ruifang Li-Gao; Mickael R Brown; Astrid van Hylckama Vlieg; Joan-Carles Souto; José-Manuel Soria; Manal Ibrahim-Kosta; Noémie Saut; Delphine Daian; Robert Olaso; Philippe Amouyel; Stéphanie Debette; Anne Boland; Pascal Bailly; Alanna C Morrison; Denis O Mook-Kanamori; Jean-François Deleuze; Andrew Johnson; Paul S de Vries; Maria Sabater-Lleal; Jacques Chiaroni; Nicholas L Smith; Frits R Rosendaal; Daniel I Chasman; David-Alexandre Trégouët; Pierre-Emmanuel Morange
Journal:  Blood       Date:  2021-04-29       Impact factor: 25.476

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.